Snoring Control Device Market Research Report - Global Forecast till 2027

Global Snoring Control Device Market Research Report: By Type (Oral Appliances/Mouthpieces, Nasal Devices, Tongue-Stabilizing Devices (TSDs), Epap Therapy Devices, Position Control Devices, Chin Straps), Distribution Channel (Retail Pharmacies and Online Stores) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027

ID: MRFR/MED/1706-HCR | February, 2021 | Region : Global

Market Scenario


Snoring Control Device Market is expected to register 4.8% CAGR during the forecast period, 2019 to 2025.


Increasing geriatric population, rising smoking and alcohol consumption, growing number of obesity cases, technological advancements in anti-snoring devices, and increased awareness in the developed markets are the key factors propelling the growth of the market. An increase in weight is a major contributor to the problem of snoring, especially in the elderly population. According to the National Sleep Foundation, in 2017, 37 million individuals faced snoring problems on a regular basis. The World Health Organization (WHO) estimated that in 2016, more than 1.9 billion adults were overweight and over 650 million were in the obese category. Among children, more than 40 million below the age of five were overweight or obese.


Segmentation


The Global Snoring Control Device Market has been segmented based on Type, Distribution Channel, and Region.


The global market, based on type, has been segmented into oral appliances/mouthpieces, nasal devices, tongue-stabilizing devices (TSDs), Epap therapy devices, position control devices and chin straps. The oral appliances/mouthpieces are further segmented into mandibular advancement devices (MADS) and tongue-retaining devices (TRDS). The mandibular advancement devices (MADS) is further segmented down to non-custom MADS and custom-made MADS. The Epap therapy devices is segmented into 3-unit bridges, 4-unit bridges, Maryland bridges, cantilever bridges, dentures, and abutments. Based on the distribution channel, the market has been further divided into retail pharmacies, online stores.


The market has been divided, by region, into Asia-Pacific, the Americas, Europe, and the Middle East & Africa. The snoring control device market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European snoring control device market has been subdivided into Western Europe and Eastern Europe. Western Europe has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The snoring control device market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The market in the Middle East & Africa has been divided into the Middle East and Africa.


Key Players


The Key Players operating in the Global Snoring Control Device Market are GlaxoSmithKline plc, Sleeping Well, LLC, ResMed, Apnea Sciences Corporation, MPowrx Health and Wellness Products, Somnomed Ltd, VitalSleep, Airway Management Inc., TheraSnore, Theravent, Inc., AirSnore, Tomed Dr, MEDiTAS, SnoreMeds, and Toussaint GmbH.


Regional Market Summary


Global Snoring Control Device Market Share, by Region, 2018 (%)  Snoring Control Device Market


Source: World Health Organization (WHO)


The market in the Americas is expected to dominate the global snoring control device market due to the increasing prevalence of obesity cases and increasing per capita healthcare expenditure in the region. Other factors such as existence of major industry players, rising number of baby boomers in the country is driving the snoring controlling devices market in the U.S. Technological advancements in the snoring treatment along with increasing investment in research and development to familiarize superior products in the market is further propelling the demand for treatment for snoring cessation in the country.


The market in Europe showed a considerable amount of growth. This can be attributed to the presence of a well-established healthcare system and increasing initiatives by government bodies for the development of new treatment options and is estimated to provide the market with high growth potential.


The market in Asia-Pacific is projected to register a steady growth rate during the forecast period owing to the increasing patient awareness about sleeping problems and growing government initiatives for healthcare reforms.  According to WHO, nearly 100,000,000 are likely to suffer from snoring problems hugely found in the age group of 55–60 years.


The market in the Middle East & Africa is projected to account for the least share of the market due to the low per capita disposable income in the region.


Global Snoring Control Device Market, by Type



  • Oral Appliances/Mouthpieces

    • Mandibular Advancement Devices (MADS)

      • Non-Custom MADS

      • Custom-Made MADS



    • Tongue-Retaining Devices (TRDS)



  • Nasal Devices

    • External Nasal Dilators

    • Others



  • Tongue-Stabilizing Devices (TSDs)

  • Epap Therapy Devices

    • 3-Unit Bridges

    • 4-Unit Bridges

    • Maryland Bridges

    • Cantilever Bridges

    • Dentures

      • Complete Dentures

      • Partial Dentures



    • Abutments

      • Temporary Abutments

      • Definitive Abutments



    • Veneers

      • Inlays and Onlays





  • Position Control Devices

  • Chin Straps


Global Snoring Control Device Market, by Distribution Channel



  • Retail Pharmacies

  • Online Stores


Global Snoring Control Device Market, by Region



  • Americas

    • North America

      • US

      • Canada



    • Latin America





  • Europe

    • Western Europe

      • Germany

      • France

      • Italy

      • Spain

      • UK

      • Rest of Western Europe



    • Eastern Europe





  • Asia-Pacific

    • Japan

    • China

    • India

    • Australia

    • South Korea

    • Rest of Asia-Pacific





  • Middle East & Africa

    • Middle East

    • Africa




Intended Audience



  • Research and development (R&D) companies

  • Medical device companies

  • Government research institutes

  • Academic institutes and universities

  • Venture capitalists

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis

6. GLOBAL SNORING CONTROL DEVICE MARKET, BY TYPE

6.1. Overview

6.2. Oral Appliances/Mouthpieces

6.2.1. Mandibular Advancement Devices (MADS)

6.2.1.1. Non-Custom MADS

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.1.2. Custom-Made MADS

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.2.2. Tongue-Retaining Devices (TRDS)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Nasal Devices

6.3.1. External Nasal Dilators

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Tongue-Stabilizing Devices (TSDs)

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5. Epap Therapy Devices

6.5.1. 3-Unit Bridges

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.2. 4-Unit Bridges

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.3. Maryland Bridges

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.4. Cantilever Bridges

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.5. Dentures

6.5.5.1. Complete Dentures

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.5.2. Partial Dentures

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.6. Abutments

6.5.6.1. Temporary Abutments

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.6.2. Definitive Abutments

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.7. Veneers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5.8. Inlays and Onlays

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6. Position Control Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.7. Chin Straps

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL SNORING CONTROL DEVICE MARKET, BY DISTRIBUTION CHANNEL

7.1. Overview

7.2. Retail Pharmacies

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Online Stores

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL SNORING CONTROL DEVICE MARKET, BY REGION

8.1. Overview

8.2. Americas

8.2.1. North America

8.2.1.1. US

8.2.1.2. Canada

8.2.2. Latin America

8.3. Europe

8.3.1. Western Europe

8.3.1.1. Germany

8.3.1.2. France

8.3.1.3. Italy

8.3.1.4. Spain

8.3.1.5. UK

8.3.1.6. Rest of Western Europe

8.3.2. Eastern Europe

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. South Korea

8.4.6. Rest of Asia-Pacific

8.5. Middle East & Africa

8.5.1. Middle East

8.5.2. Africa

9. COMPANY LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategies in the Global Snoring Control Device Market

9.5. Competitive Benchmarking

9.6. Leading Players in Terms of the Number of Developments in the Global Snoring Control Device Market

9.7. Key developments and Growth Strategies

9.7.1. Product Launch/Service Deployment

9.7.2. Mergers and Acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix & Market Ratio

9.8.1. Sales & Operating Income 2020

9.8.2. Major Players R&D Expenditure 2020

9.9. Major Players Capital Market Ratio

10. COMPANY PROFILES

10.1. GlaxoSmithKline plc

10.1.1. Company Overview

10.1.2. Product Overview

10.1.3. Financial Overview

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Sleeping Well, LLC

10.2.1. Company Overview

10.2.2. Product Overview

10.2.3. Financial Overview

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. ResMed

10.3.1. Company Overview

10.3.2. Product Overview

10.3.3. Financial Overview

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Apnea Sciences Corporation

10.4.1. Company Overview

10.4.2. Product Overview

10.4.3. Financial Overview

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. MPowrx Health and Wellness Products

10.5.1. Company Overview

10.5.2. Product Overview

10.5.3. Financial Overview

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Somnomed Ltd

10.6.1. Company Overview

10.6.2. Product Overview

10.6.3. Financial Overview

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. VitalSleep

10.7.1. Company Overview

10.7.2. Product Overview

10.7.3. Financial Overview

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Airway Management Inc.

10.8.1. Company Overview

10.8.2. Product Overview

10.8.3. Financial Overview

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. TheraSnore

10.9.1. Company Overview

10.9.2. Product Overview

10.9.3. Financial Overview

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Theravent, Inc.

10.10.1. Company Overview

10.10.2. Product Overview

10.10.3. Financial Overview

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

10.11. AirSnore

10.11.1. Company Overview

10.11.2. Product Overview

10.11.3. Financial Overview

10.11.4. Key Developments

10.11.5. SWOT Analysis

10.11.6. Key Strategies

10.12. Tomed Dr

10.12.1. Company Overview

10.12.2. Product Overview

10.12.3. Financial Overview

10.12.4. Key Developments

10.12.5. SWOT Analysis

10.12.6. Key Strategies

10.13. MEDiTAS

10.13.1. Company Overview

10.13.2. Product Overview

10.13.3. Financial Overview

10.13.4. Key Developments

10.13.5. SWOT Analysis

10.13.6. Key Strategies

10.14. SnoreMeds

10.14.1. Company Overview

10.14.2. Product Overview

10.14.3. Financial Overview

10.14.4. Key Developments

10.14.5. SWOT Analysis

10.14.6. Key Strategies

10.15. Toussaint Gmbh

10.15.1. Company Overview

10.15.2. Product Overview

10.15.3. Financial Overview

10.15.4. Key Developments

10.15.5. SWOT Analysis

10.15.6. Key Strategies

11. APPENDIX

11.1. References

11.2. Related Reports


LIST OF TABLES

TABLE 1 GLOBAL SNORING CONTROL DEVICE MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL SNORING CONTROL DEVICE MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL SNORING CONTROL DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL SNORING CONTROL DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL SNORING CONTROL DEVICE MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 6 NORTH AMERICA: SNORING CONTROL DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: SNORING CONTROL DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 8 US: SNORING CONTROL DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 9 US: SNORING CONTROL DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 10 CANADA: SNORING CONTROL DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 11 CANADA: SNORING CONTROL DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 12 LATIN AMERICA: SNORING CONTROL DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 13 LATIN AMERICA: SNORING CONTROL DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 14 EUROPE: SNORING CONTROL DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 15 EUROPE: SNORING CONTROL DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 16 WESTERN EUROPE: SNORING CONTROL DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 17 WESTERN EUROPE: SNORING CONTROL DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 18 EASTERN EUROPE: SNORING CONTROL DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 19 EASTERN EUROPE: SNORING CONTROL DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC: SNORING CONTROL DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 21 ASIA-PACIFIC: SNORING CONTROL DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA: SNORING CONTROL DEVICE MARKET, BY TYPE, 2020-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA: SNORING CONTROL DEVICE MARKET, BY DISTRIBUTION CHANNEL, 2020-2027 (USD MILLION)


LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE OF THE GLOBAL SNORING CONTROL DEVICE MARKET

FIGURE 3 MARKET DYNAMICS OF THE GLOBAL SNORING CONTROL DEVICE MARKET

FIGURE 4 GLOBAL SNORING CONTROL DEVICE MARKET SHARE, BY TYPE, 2020 (%)

FIGURE 5 GLOBAL SNORING CONTROL DEVICE MARKET SHARE, BY DISTRIBUTION CHANNEL, 2020 (%)

FIGURE 6 GLOBAL SNORING CONTROL DEVICE MARKET SHARE, BY REGION, 2020 (%)

FIGURE 7 AMERICAS: SNORING CONTROL DEVICE MARKET SHARE BY REGION, 2020 (%)

FIGURE 8 NORTH AMERICA: SNORING CONTROL DEVICE MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 9 EUROPE: SNORING CONTROL DEVICE MARKET SHARE, BY REGION, 2020 (%)

FIGURE 10 WESTERN EUROPE: SNORING CONTROL DEVICE MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 11 ASIA-PACIFIC: SNORING CONTROL DEVICE MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 12 MIDDLE EAST & AFRICA: SNORING CONTROL DEVICE MARKET SHARE, BY COUNTRY, 2020 (%)

FIGURE 13 GLOBAL SNORING CONTROL DEVICE MARKET: COMPANY SHARE ANALYSIS, 2020 (%)

FIGURE 14 GLAXOSMITHKLINE PLC: KEY FINANCIALS

FIGURE 15 GLAXOSMITHKLINE PLC: SEGMENTAL REVENUE

FIGURE 16 GLAXOSMITHKLINE PLC: REGIONAL REVENUE

FIGURE 17 SLEEPING WELL, LLC: KEY FINANCIALS

FIGURE 18 SLEEPING WELL, LLC: SEGMENTAL REVENUE

FIGURE 19 SLEEPING WELL, LLC: REGIONAL REVENUE

FIGURE 20 RESMED: KEY FINANCIALS

FIGURE 21 RESMED: SEGMENTAL REVENUE

FIGURE 22 RESMED: REGIONAL REVENUE

FIGURE 23 APNEA SCIENCES CORPORATION: KEY FINANCIALS

FIGURE 24 APNEA SCIENCES CORPORATION: SEGMENTAL REVENUE

FIGURE 25 APNEA SCIENCES CORPORATION: REGIONAL REVENUE

FIGURE 26 MPOWRX HEALTH AND WELLNESS PRODUCTS: KEY FINANCIALS

FIGURE 27 MPOWRX HEALTH AND WELLNESS PRODUCTS: SEGMENTAL REVENUE

FIGURE 28 MPOWRX HEALTH AND WELLNESS PRODUCTS: REGIONAL REVENUE

FIGURE 29 SOMNOMED LTD: KEY FINANCIALS

FIGURE 30 SOMNOMED LTD: SEGMENTAL REVENUE

FIGURE 31 SOMNOMED LTD: REGIONAL REVENUE

FIGURE 32 VITALSLEEP: KEY FINANCIALS

FIGURE 33 VITALSLEEP: SEGMENTAL REVENUE

FIGURE 34 VITALSLEEP: REGIONAL REVENUE

FIGURE 35 AIRWAY MANAGEMENT INC.: KEY FINANCIALS

FIGURE 36 AIRWAY MANAGEMENT INC. SEGMENTAL REVENUE

FIGURE 37 AIRWAY MANAGEMENT INC.: REGIONAL REVENUE

FIGURE 38 THERASNORE: KEY FINANCIALS

FIGURE 39 THERASNORE: SEGMENTAL REVENUE

FIGURE 40 THERASNORE: REGIONAL REVENUE

FIGURE 41 THERAVENT, INC. KEY FINANCIALS

FIGURE 42 THERAVENT, INC.: SEGMENTAL REVENUE

FIGURE 43 THERAVENT, INC.: REGIONAL REVENUE

FIGURE 44 AIRSNORE: KEY FINANCIALS

FIGURE 45 AIRSNORE: SEGMENTAL REVENUE

FIGURE 46 AIRSNORE: REGIONAL REVENUE

FIGURE 47 TOMED DR: KEY FINANCIALS

FIGURE 48 TOMED DR: SEGMENTAL REVENUE

FIGURE 49 TOMED DR: REGIONAL REVENUE

FIGURE 50 MEDITAS: KEY FINANCIALS

FIGURE 51 MEDITAS: SEGMENTAL REVENUE

FIGURE 52 MEDITAS: REGIONAL REVENUE

FIGURE 53 SNOREMEDS: KEY FINANCIALS

FIGURE 54 SNOREMEDS: SEGMENTAL REVENUE

FIGURE 55 SNOREMEDS: REGIONAL REVENUE

FIGURE 56 TOUSSAINT GMBH: KEY FINANCIALS

FIGURE 57 TOUSSAINT GMBH: SEGMENTAL REVENUE

FIGURE 58 TOUSSAINT GMBH: REGIONAL REVENUE

Snoring Control Device Market